Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-55

not sure Sarepta holders would enjoy seeing us go to market showing true efficacy as a micro cap whilst they sit on a few billion in cash to prop up their SP and not much else. Unlike that article there isn't huge competition for us, and a lot at stake for those that are. I'm sure he's right things have changed, but to say that's what will happen to us.... bit like trying to predict what the company will do next from an online share chat room, no one got it right with the recent announcements, including this one.